BANK VONTOBEL/CALL/SANOFI/100/0.1/20.09.24 Share Price

Warrant

DE000VM3T1H4

Market Closed - Deutsche Boerse AG 18:53:38 02/07/2024 BST
0.105 EUR -25.53% Intraday chart for BANK VONTOBEL/CALL/SANOFI/100/0.1/20.09.24
Current month+3.96%
1 month+6.06%
Date Price Change
02/07/24 0.105 -25.53%
01/07/24 0.141 +39.60%
28/06/24 0.101 +16.09%
27/06/24 0.087 -30.95%
26/06/24 0.126 -10.00%

Delayed Quote Deutsche Boerse AG

Last update July 02, 2024 at 06:53 pm

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellCALL
Underlying SANOFI
IssuerLogo Issuer Vontobel Vontobel
WKN VM3T1H
ISINDE000VM3T1H4
Date issued 10/10/2023
Strike 100
Maturity 20/09/2024 (80 Days)
Parity 10 : 1
Emission price 1.01
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 1.16
Lowest since issue 0.059
Spread 0.039
Spread %27.46%

Company Profile

Sanofi is the largest European pharmaceutical group. Net sales by family of products break down as follows: - pharmaceutical products (70.6%): prescription drugs in the areas of specialty medicine (59.3% of net sales; for the treatment of multiple sclerosis, neurological diseases, inflammatory diseases, autoimmune diseases, rare diseases, cancers and rare hematological diseases) and general medicine (40.7%; mainly for the treatment of diabetes and cardiovascular diseases); - human vaccines (17.4%): pediatric vaccines, vaccines for flu, meningitis, and polio, booster vaccines, and vaccines for travelers and endemic areas; - consumer health products (12%). At the end of 2023, the group had 54 production sites throughout the world. Net sales are distributed geographically as follows: France (5.5%), Europe (18.6%), the United States (43%), North America (1.6%) and other (31.3%).
Sector
-
More about the company

Ratings for Sanofi

Trading Rating
Investor Rating
ESG Refinitiv
B+
More Ratings

Consensus: Sanofi

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
23
Last Close Price
90.44 EUR
Average target price
108.1 EUR
Spread / Average Target
+19.52%
Consensus